ask="N/A"
ask_size="N/A"
average_daily_volume="4276"
bid="N/A"
bid_size="N/A"
book_value="0.95"
change="N/A"
change_from_200_day_moving_average="-0.39"
change_from_50_day_moving_average="-0.20"
change_from_52_week_high="-2.59"
change_From_52_week_low="0.44"
change_in_percent="N/A"
close="2.66"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.44"
ebitda="-13.25M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.07"
eps_estimate_next_year="-0.33"
ex_dividend_date="N/A"
float_shares="23083000"
high="N/A"
high_52_weeks="5.25"
last_trade_date="2/13/2017"
last_trade_price="2.66"
last_trade_size="N/A"
last_trade_time="3:59pm"
low="N/A"
low_52_weeks="2.22"
market_capitalization="95.06M"
moving_average_200_day="3.05"
moving_average_50_day="2.86"
name="Oasmia Pharmaceutical AB"
notes="N/A"
one_year_target_price="6.00"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-12.89%"
percent_change_from_50_day_moving_average="-6.91%"
percent_change_from_52_week_high="-49.33%"
percent_change_from_52_week_low="+19.82%"
previous_close="2.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.80"
price_per_sales="52.42"
revenue="1.81M"
shares_outstanding="35736000"
short_ratio="0.43"
stock_exchange="NCM"
symbol="OASM"
volume="0"
weeks_range_52="2.22 - 5.25"
